LUPRON DEPOT® (leuprolide acetate for depot suspension) 7.5 mg for 1‑month, 22.5 mg for 3-month, 30 mg for 4‑month, and 45 mg for 6‑month administration are indicated for the treatment of advanced prostatic cancer.
US-LUPR-220201
Please click here for Full Prescribing Information.
LUPRON DEPOT [package insert]. North Chicago, IL: AbbVie Inc; 2019.